Improved anti-breast cancer activity by doxorubicin-loaded super stealth liposomes
Donatella Paolino, Nicola d’Avanzo, Elena Canato, Luigi Ciriolo, Antonella Grigoletto, Maria Chiara Cristiano, Antonia Mancuso, Christian Celia, Gianfranco Pasut, Massimo Fresta
Abstract
administration and could significantly increase the efficacy of doxorubicin in breast cancer lung metastasis tumor-bearing mice compared to the free drug. The super stealth liposomes also increased doxorubicin accumulation inside the tumor tissue. The permanence of PEG on the surface of the super stealth liposomes favored the formation of a depot of therapeutic nanocarriers inside the tumor tissue by improving their permanence after stopping treatment. The doxorubicin-loaded super stealth liposomes increased the survival of the mouse tumor model. These promising results demonstrate that the doxorubicin-loaded super stealth liposomes could be an effective nanomedicine to treat metastatic breast cancer.